Lv1
40 积分 2023-11-10 加入
CAR T-cell therapy in autoimmune diseases: where are we and where are we going?
2天前
已完结
B cell activating factor (BAFF): Structure, functions, autoimmunity and clinical implications in Systemic Lupus Erythematosus (SLE)
14天前
已完结
B-cell depletion in autoimmune diseases
17天前
已完结
Opportunities and limitations of B cell depletion approaches in SLE
18天前
已完结
Bispecific and multispecific antibodies in oncology: opportunities and challenges
25天前
已完结
Next-generation combination approaches for immune checkpoint therapy
25天前
已完结
Multimodal targeting chimeras enable integrated immunotherapy leveraging tumor-immune microenvironment
26天前
已完结
Ex silico engineering of cystine-dense peptides yielding a potent bispecific T cell engager
27天前
已完结
Development of bifunctional anti-PD-L1 antibody MMAE conjugate with cytotoxicity and immunostimulation
1个月前
已完结
181 (PB169): DB-1419, a first-in-class bispecific ADC targeting B7-H3 and PD-L1 with a DNA topoisomerase I inhibitor, exhibits promising efficacy and safety in preclinical models
1个月前
已完结
皖公网安备34019202002308
